Keywords: crixivan, invirase, cleared, eu, hiv, european, commission
Crixivan And Invirase Cleared In EU For HIV
Article | 14 October 1996
The European Commission has approved two more protease inhibitors, Merck & Co's Crixivan (indinavir) and Hoffmann-La Roche's Invirase (saquinavir), for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
